Anti-Infective · Critical Care Injectable
RILCEFTA-500
Ceftriaxone 500 mg
WHO-GMP manufactured by Biofril Healthcare. Available for hospital tenders, ICU supply, and PCD franchise distribution across India.
Product Specifications
RILCEFTA-500 at a Glance
| Brand Name | RILCEFTA-500 |
|---|---|
| Composition | Ceftriaxone 500 mg |
| Therapeutic Category | Anti-Infective |
| Division | Critical Care Injectable |
| Pack / Presentation | Vial + Water |
| Storage | Store below 25°C. Protect from light. |
| Manufacturer | Biofril Healthcare Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP |
| Prescription Status | Rx — sold by retail on the prescription of a Registered Medical Practitioner |
Clinical Use
Indications & Clinical Use
RILCEFTA-500 (Ceftriaxone 500 mg) is indicated for the treatment of infections and conditions where ceftriaxone therapy is clinically appropriate. For complete prescribing information, indications, dosing, contraindications, and safety profile, please refer to the official product insert.
This page provides product identification information only. Clinical decisions must be made by a qualified medical practitioner based on the complete prescribing information.
Why Biofril
Quality You Can Audit
- WHO-GMP manufactured at our Nalagarh, Himachal Pradesh facility
- Certificate of Analysis (COA) issued with every batch
- ISO 9001:2015 Quality Management System
- Stability data per ICH guidelines
- Hospital tender documentation ready on request
- Available for PCD franchise distribution with monopoly district rights
Enquire About RILCEFTA-500
PCD franchise · Hospital tenders · Bulk supply · Distribution